Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Apothekerstiftung Nordrhein, Duesseldorf | UNKNOWN |
| Foerderinitiative Pharmazeutische Betreuung e.V., Berlin | UNKNOWN |
The purpose of this study is to determine whether additional pharmaceutical care for elderly patients (home-cared patients, nursing-home residents) has a positive impact on drug-related readmissions.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| standard care | No Intervention | Standard care (by German definition), traditional care by physician and nurse on the ward | |
| Intensified standard care | Other | Intensified standard care: traditional care by physician and nurse, additional pharmaceutical care by a pharmacist during hospitalization |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Pharmaceutical Care Service | Other | Checking medication under safety considerations (medication at admission, hospitalization, discharge); recommendations for potentially inappropriate medication (PRISCUS-criteria), |
| Measure | Description | Time Frame |
|---|---|---|
| Drug-related readmission | one year after discharge from the cooperating ward |
| Measure | Description | Time Frame |
|---|---|---|
| Adverse drug events | during hospital stay on cooperating wards(continuous data collection during routine ward rounds;hence,duration of data collection is dependent on individual hospital stay of each patient, up to 1 year) and 1 year after discharge from the cooperating ward | |
| Number of prescribed potentially inappropriate medication (PRISCUS-criteria) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Albrecht Eisert, Dr. rer. nat. | University Hospital Aachen, Hospital Pharmacy, Steinbergweg 20, 52074 Aachen, Germany | Study Director |
| Axel Heidenreich, Prof. Dr. med. | University Hospital Aachen, Department of Urology, Pauwelsstr. 30, 50274 Aachen, Germany | Principal Investigator |
| Joerg B Schulz, Prof. Dr. med. | University Hospital Aachen, Department of Neurology, Pauwelsstr. 30, 52074 Aachen, Germany | Principal Investigator |
| Christian Trautwein, Prof. Dr. med. | University Hospital Aachen, Internal Medicine III (Gastroenterology and Metabolic Disorders), Pauwelsstr. 30, 52074 Aachen, Germany | Principal Investigator |
| Ulrich Jaehde, Prof. Dr. rer. nat. | University of Bonn, Pharmaceutical Institute, Clinical Pharmacy, An der Immenburg 4, 53121 Bonn, Germany | Study Chair |
| Rebekka Heumueller | University Hospital Aachen, Hospital Pharmacy, Steinbergweg 20, 52074 Aachen, Germany | Principal Investigator |
| Nicolaus Marx, Prof. Dr. med. | University Hospital Aachen,Internal Medicine I (Cardiology, Pneumology, Angiology and Internal Intensive Medicine) | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University Hospital Aachen | Aachen | Germany |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 29898670 | Derived | Lenssen R, Schmitz K, Griesel C, Heidenreich A, Schulz JB, Trautwein C, Marx N, Fitzner C, Jaehde U, Eisert A. Comprehensive pharmaceutical care to prevent drug-related readmissions of dependent-living elderly patients: a randomized controlled trial. BMC Geriatr. 2018 Jun 4;18(1):135. doi: 10.1186/s12877-018-0814-3. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D010593 | Pharmaceutical Services |
| ID | Term |
|---|---|
| D006296 | Health Services |
| D005159 | Health Care Facilities Workforce and Services |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The PRISCUS list was developed in 2010 for the German market. Potentially inappropriate medications were judged as inappropriate by an expert panel using the Delphi technique. [Holt et al., Dtsch Arztebl 2010] |
| during hospital stay on cooperating wards(continuous data collection during routine ward rounds;hence,duration of data collection is dependent on individual hospital stay of each patient, up to 1 year) and 1 year after discharge from the cooperating ward |
| time to readmission | one year after discharge from the cooperating ward |
| Number of accepted recommendations in the intervention group | during hospital stay on cooperating wards (continuous data collection during routine ward rounds; hence, duration of data collection is dependent on individual hospital stay of each patient, up to one year) in the intervention group |
| time for intervention | time recording for pharmaceutical care service | during hospital stay on cooperating wards (continuous data collection during routine ward rounds; hence, duration of data collection is dependent on individual hospital stay of each patient, up to one year) in the intervention group |
| drug-related problem | during hospital stay on cooperating wards (continuous data collection during routine ward rounds; hence, duration of data collection is dependent on individual hospital stay of each patient, up to one year) in the intervention group |
| number of changes in medication after discharge | one year |